Pharmacologic aspects of homofolate derivatives in relation to amethopterin-resistant murine leukemia.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001681:Biological Assay; D013293:Enterococcus faecalis / Q000378:metabolism; D005492:Folic Acid / Q000097:blood / Q000494:pharmacology* / Q000633:toxicity*; D007939:Leukemia L1210 / Q000188:drug therapy*; D008025:Ligases / Q000378:metabolism; D008297:Male; D008727:Methotrexate / Q000494:pharmacology*; D051379:Mice; D009711:Nucleotides / Q000378:metabolism; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism
D000970:Antineoplastic Agents; D009711:Nucleotides; D005492:Folic Acid; D013762:Tetrahydrofolate Dehydrogenase; D008025:Ligases; D008727:Methotrexate